Montreux Capital Management, a Swiss investment firm specialising in alternative and boutique funds and Investment Advisor to the Montreux Care Home Fund, and KTN Care, a multi-family office with expertise in healthcare,  today announced the purchase of ACH, a Learning Disability care homes business with freehold real-estate backing based in the south east of England.

Macquarie Lending, part of Macquarie’s Corporate and Asset Finance Group, has provided a loan and minority equity against the deal. The Montreux Care Home Fund will be the majority equity holder with KTN Care providing management expertise and minority equity.

Oliver Harris, Managing Partner at Montreux Capital Management commented: “We are delighted to be working with trusted partners KTN Care and Macquarie to provide a platform for ACH to expand its high-quality service throughout the UK.  ACH is a proven specialist in its field and the funding for this next stage of its development is testament to the belief of the participants in the company’s potential. ”

Tayvanie Nagendran at KTN Care, who will be the new CEO of ACH said, “We are delighted to be partnering with Macquarie and Montreux on this acquisition. ACH is a fantastic company that delivers high quality care to adults with learning disabilities and under our stewardship we can really look forward to taking this company to another level.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT